Clinical Trials Logo

Clinical Trial Summary

The aim of this randomized trial is to assess the utility of Surgical Pleth Index (SPI) for monitoring pain perception intraoperatively and its influence on intraoperative blood loss, quality of surgical field using Boezaart Bleeding Scale (BBS) in patients undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol or volatile anaesthesia using sevoflurane or desflurane


Clinical Trial Description

Intraoperative blood loss during FESS constitutes a major problem for a surgeon because it influences quality of surgical field. Each incident of haemorrhage makes the operator stop the procedure in order to bring back the optimal visualization of the intranasal anatomy. In the end it prolongs the time of procedure. Currently, intraoperative blood loss is estimated based on Boezaart Bleeding Scale (BBS) (0 - no bleeding (cadaveric conditions), 1 - Slight bleeding, no suctioning required, 2 - Slight bleeding, occasional suctioning required, 3 - Slight bleeding, frequent suctioning required; bleeding threatens surgical field a few seconds after suction is removed, 4 - Moderate bleeding, frequent suctioning required, and bleeding threatens surgical field directly after suction is removed, 5 - Severe bleeding, constant suctioning required; bleeding appears faster than can be removed by suction; surgical field severely threatened and surgery usually not possible). Recently, the Surgical Pleth Index (SPI) was added as a surrogate variable showing the nociception-antinociception balance into above mentioned parameters constituting a novel approach in monitoring patients intraoperatively, known as adequacy of anaesthesia (AoA) or tailor-made anaesthesia. SPI>10 or any SPI>50, were proposed to constitute the indication for administration of rescue analgesia intraoperatively. This study aims at evaluating utility of SPI-guided analgesia using remifentanil on the intraoperative blood loss, haemodynamic stability and time duration of surgery in patients undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol or volatile anaesthesia using sevoflurane or desflurane. Currently, FESS is most often performed using total intravenous anaesthesia (TIVA) which is by majority of anaesthesiologists believed to reduce the intraoperative blood loss compared to general anaesthesia using volatile anaesthetics, but current literature provides conflicting findings in this area if the sort of anaesthetic used influences quality of the surgical field. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03417180
Study type Interventional
Source Medical University of Silesia
Contact Michal J Stasiowski, MD
Phone 696797922
Email mstasiowski.anest@gmail.com
Status Recruiting
Phase N/A
Start date September 1, 2018
Completion date July 15, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04078659 - Propofol and Magnesium Sulfate Intravenous Infusion During Endoscopic Sinus Surgery N/A
Not yet recruiting NCT03417206 - PRD-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Completed NCT02692794 - Large Scale Cerebral Oximetry During Sinus Endoscopy N/A
Completed NCT05930132 - The Role of the Submucosal Conchoplasty Technique in Improving the Postoperative Middle Meatus Outcome After ESS N/A
Not yet recruiting NCT05829148 - The Effect of Dexmedetomidine, Melatonin and Pregabalin Early Phase 1
Completed NCT03229551 - Xylitol for Chronic Sinusitis Phase 2/Phase 3
Active, not recruiting NCT04356196 - Comparative Study Between the Efficacy of Verapamil and Bisoprolol on Reduction of Bleeding During Endoscopic Sinus Surgery Under General Anaesthesia. Early Phase 1
Completed NCT03228914 - Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery Phase 4
Completed NCT03389763 - SPI-guided vs PRD-guided Analgesia During FESS for Intraoperative Blood Loss N/A
Completed NCT02182492 - Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery N/A
Recruiting NCT04852562 - The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps N/A
Recruiting NCT05145543 - Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery Phase 2/Phase 3
Completed NCT02748070 - Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP) N/A
Completed NCT01564355 - Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery N/A